Acorai is a healthcare technology startup that focuses on heart failure management. The company has developed a non-invasive and scalable solution to assist healthcare professionals in managing intracardiac pressures, which are crucial for understanding and managing heart failure. The solution, known as the SAVE Sensor System, uses a unique combination of Seismic, Acoustic, Visual, and Electrocardiographic sensors to estimate intracardiac pressures.

The company's technology is built on state-of-the-art machine learning, using proprietary datasets and data partnerships with leading hospitals. The handheld and portable device is designed to integrate easily into daily medical practice, providing accurate, absolute, and actionable non-invasive intracardiac pressure monitoring.

The Acorai Heart Monitor aims to offer accurate estimations of pulmonary pressure, supporting personalized heart failure treatment. Acorai is currently conducting a clinical study, CAPTURE-HF, to confirm if the monitor can deliver actionable information equivalent to invasive methods.

Acorai's business model revolves around selling this technology to healthcare professionals and hospitals. By providing a better understanding of patient stability, the technology can help reduce readmission rates and length of stay, leading to cost savings for hospitals and improved patient outcomes.

The company operates in the healthcare technology market, serving healthcare professionals and hospitals that deal with heart failure patients. Acorai's mission is to alleviate healthcare burdens by enabling data-driven, personalized treatment.

Keywords: Heart Failure Management, Non-Invasive Technology, Intracardiac Pressures, Healthcare Professionals, Machine Learning, Proprietary Datasets, Acorai Heart Monitor, Personalized Treatment, Readmission Rates, Patient Stability.